Stoke Therapeutics at Guggenheim: dravet data build launch case

🌐 Investing.com (Cyprus) —
Stoke Therapeutics at Guggenheim: dravet data build launch case

AI Summary

Stoke Therapeutics presented Dravet syndrome data at the Guggenheim healthcare conference, with results described as strengthening the case for a potential launch. The headline does not provide specific data or a launch timeline.

Markets Health Stoke Therapeutics Dravet syndrome clinical data drug launch Guggenheim conference

Read original source →